PRGO 28.16 (+0.5%)
IE00BGH1M568Drug ManufacturersDrug Manufacturers - Specialty & Generic

Perrigo (PRGO) Competitor Comparison

We are evaluating the key criteria listed to compare Perrigo (PRGO) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 10 years - PRGO ranking 34 / 54

These are the competitors of Perrigo in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 10 years
1. Phibro Animal Health PAHC
72.8
2. Theratechnologies THTX
31.25
3. Green Thumb Industries R9U2.F
19.05
4. Avadel Pharmaceuticals AVDL
19.05
5. Alvotech ALVO
18.17
6. Eagle Pharmaceuticals EGRX
12.82
7. Kamada KMDA
12.01
8. Regencell Bioscience Holdings RGC
9.12
9. Vifor Pharma G2AB.F
7.23
10. Emergent BioSolutions EBS
6.87
11. ProPhase Labs PRPH
6.65
12. PetIQ PETQ
5.63
13. Linc LNC
4.98
14. Kolinpharma KIP.MI
4.84
15. Ironwood Pharmaceuticals IRWD
4.8
16. Ayr Wellness 3KJB.F
4.47
17. Alimera Sciences ALIM
4.31
18. Societal CDMO SCTL
3.72
19. Curaleaf Holdings CURLF
3.55
20. Elanco Animal Health ELAN
3.39
21. Cumberland Pharmaceuticals CPIX
3.31
22. Organogenesis Holdings ORGO
3.22
23. Amneal Pharmaceuticals AMRX
3.1
24. Evolus EOLS
2.92
25. Taro Pharmaceutical Industries TARO
2.87
26. Procaps Group PROC
2.81
27. Cronos Group CRON
2.76
28. Embecta EMBC
2.68
29. Journey Medical DERM
2.55
30. ANI Pharmaceuticals ANIP
2.43
31. Teva Pharmaceutical Industries TEVA
2.4
32. Tilray Brands TLRY
2.37
33. Neoleukin Therapeutics NLTX
2.29
34. Perrigo PRGO
2.19
35. Pacira BioSciences PCRX
2.13
36. Catalent CTLT
2.11
37. Jupiter Wellness JUPW
1.84
38. Alpha Teknova TKNO
1.78
39. Biofrontera BFRI
1.78
40. Flora Growth FLGC
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. OptiNose OPTN
1.72
43. Bausch Health Companies BHC
1.71
44. Zynerba Pharmaceuticals ZYNE
1.63
45. Solid Biosciences SLDB
1.63
46. Relmada Therapeutics RLMD
1.62
47. Clever Leaves Holdings CLVR
1.62
48. Universe Pharmaceuticals UPC
1.58
49. SCYNEXIS SCYX
1.56
50. Supernus Pharmaceuticals SUPN
1.51
51. Harrow Health HROW
0.66
52. Collegium Pharmaceutical COLL
0.64
53. Zoetis ZTS
0.52
54. Amphastar Pharmaceuticals AMPH
0.39

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.